ILLUMINATE RX FLEXCHOICE FORMULARY Trademark

Trademark Overview


On Wednesday, December 3, 2025, a trademark application was filed for ILLUMINATE RX FLEXCHOICE FORMULARY with the United States Patent and Trademark Office. The USPTO has given the ILLUMINATE RX FLEXCHOICE FORMULARY trademark a serial number of 99527378. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, April 16, 2026. This trademark is owned by Illuminate Rx, Inc.. The ILLUMINATE RX FLEXCHOICE FORMULARY trademark is filed in the Insurance & Financial Services category with the following description:

Pharmacy benefit management services
illuminate rx flexchoice formulary

General Information


Serial Number99527378
Word MarkILLUMINATE RX FLEXCHOICE FORMULARY
Filing DateWednesday, December 3, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, April 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmacy benefit management services

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, December 3, 2025
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIlluminate Rx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 35243
US

Trademark Events


Event DateEvent Description
Wednesday, December 3, 2025NEW APPLICATION ENTERED
Wednesday, December 3, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 12, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 7, 2026ASSIGNED TO EXAMINER
Thursday, April 16, 2026NON-FINAL ACTION WRITTEN
Thursday, April 16, 2026NON-FINAL ACTION E-MAILED
Thursday, April 16, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED